![Blueprint Medicines Corporation](/common/images/company/N_BPMC.png)
Blueprint Medicines Corp is a biopharmaceutical company. It is focused on improving the lives of patients with diseases driven by abnormal kinase activation. The company has developed a small molecule drug pipeline in cancer and a rare genetic disease. Its drug candidates BLU-285, which targets KIT ... Blueprint Medicines Corp is a biopharmaceutical company. It is focused on improving the lives of patients with diseases driven by abnormal kinase activation. The company has developed a small molecule drug pipeline in cancer and a rare genetic disease. Its drug candidates BLU-285, which targets KIT Exon 17 mutants and PDGFRa D842V, abnormally active receptor tyrosine kinase mutants that are drivers of cancer and proliferative disorders. Its other drug candidate is BLU 554 FOR Advanced Hepatocellular Carcinoma, and BLU-667 for Ret Mutations, Fusions, and Predicted Resistant Mutants. Show more
Blueprint Medicines to Report Second Quarter 2024 Financial Results on Thursday, August 1, 2024 PR Newswire CAMBRIDGE, Mass., July 18, 2024 CAMBRIDGE, Mass., July 18, 2024 /PRNewswire/...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -4.85 | -4.04773827408 | 119.82 | 121.9 | 109.5 | 764498 | 116.5088678 | CS |
4 | 8.94 | 8.43157596907 | 106.03 | 121.9 | 101.78 | 668158 | 112.06970886 | CS |
12 | 22.21 | 23.9435101337 | 92.76 | 121.9 | 90.47 | 617586 | 106.82972824 | CS |
26 | 34.92 | 43.6227357901 | 80.05 | 121.9 | 72.24 | 701554 | 95.39173847 | CS |
52 | 57.43 | 99.8088286409 | 57.54 | 121.9 | 43.89 | 723103 | 79.02836848 | CS |
156 | 32.77 | 39.8661800487 | 82.2 | 121.9 | 37.82 | 657184 | 69.08965935 | CS |
260 | 16.41 | 16.6497564935 | 98.56 | 125.61 | 37.82 | 608950 | 73.00666262 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.